Agenda at a Glance

Don't miss out on all of these great opportunities
Please note: This agenda does not contain session descriptions. Download the full program for complete conference details.

Wednesday, September 14, 2011

Pre-conference Symposium

Pre-conference Workshop

No-Fee add on

B1: MDRP Operational, Systems, Financial, and legal Compliance with Healthcare Reform

B2: Medicaid Drug Rebate Program Fundamentals -

9:00 -12:00 MDRP Dispute Resolution Meetings

8:00	Registration and Morning Coffee
8:45	Chairperson's Opening Remarks Pamela Vaal, Ret. Lilly
9:00	Status Update of Healthcare Reform's Impact on Pharma Alice Valder Curran, Hogan Lovells US llP
9:45	AMP Definitions and Calculations: Keys to Reasonable Assumptions session David Chan, Principal, Marina Consulting
11:00	Key legal Issues and Risks Associated with Continued Implementation of Healthcare Reform Constance A. Wilkinson, EBG
11:30	Status of 340B Program Guidance, Integrity Provisions and Dispute Processes Katie Lapins, Government Pricing Specialists Kathleen Black, Pfizer Catrina Hirschauer, Upsher-Smith Jen Norton, I-many

8:00	Registration and Morning Coffee
8:45	Workshop Introduction and Overview Linda l. Schock, CIS
10:30	Refreshment Break
11:00	Fundamentals of the MDRP for Manufacturers Processes

30 minute sessions Facilitated by: tamara Bruce, technical director, CMS States invited or confirmed for 2011 at Press time
- Arizona Florida Illinois - Jeff Naber -	- - North Carolina - Sharon Greeson Oklahoma - Tom Simonson Pennsylvania - Jennifer Dudeck
Contact Anne Reel at AReel@iirusa.com

12:00	Networking Luncheon
1:30	Proactive & Strategic Pricing Policies Susan Dunne, & Michelle Scheid, Huron Life Sciences
	PANEL DISCUSSION
2:00	Key Lessons Learned in Estimating and Accruing for the Pharmaceutical Industry Fees Aaron Vandervelde, BRG Health Analytics Pratice
2:30	Managed Medicaid and Best Practices in Handling Increased Medicaid Claim Volumes Jesse Mendelsohn, Model N
3:00	Afternoon Networking Break
3:30	Strategies for Situational Analysis to Ensure Appropriate Rebate Accruals During Uncertain Times Chester Schwartz, Collaborative Consulting
4:00	Transition to GP GAME

12:00	Networking Luncheon
1:30	Understand the Role of State Medicaid Officials Jeff Naber, Illinois
3:00	Refreshment Break
3:30	Working with NCPDP Kay Morgan, Gold Standard
4:00	Transition to GP GAME

INVITE ONLY

1:30 Senior Leadership Summit
Quantify the Impact of Healthcare Reform on corporate Financials

the mission of this forum is give pharmaceutical executives specific information from the leading Consultants and attorneys on the impact of Healthcare reform. the format provides an opportunity to dialog with other senior leaders from different type/size pharmaceutical manufacturers about changing business strategies.

Moderators:
Katherine Buckley PWC

Panelists:
Thomas Gorga, Daiichi Sankyo Inc
Jason Brandwene, Gilead Sciences
Mike Borgia, JJHCS
Matt Phillips, Victory Pharma
Sanjida Chowdhury, APP Pharmaceuticals
Jay McKinley, Cephalon

Thursday, September 15, 2011
7:30	Registration and Morning Coffee
8:15	Chairperson's Welcome Edward J. McAdam, Daiichi Sankyo Inc
SECRET KEYNOTE ADDRESS
8:30	Inside America's Healthcare Reform Governor Howard Dean
CMS POLICY & OPERATIONS UPDATES
9:15	Current CMS Policy Initiatives, Rebate, Data, Operations and Technical/Systems Updates Policy: Kimberly M. Howell, MBA, CMS • Wendy Tuttle, CMS Operations: Tamara Bruce, CMS • Samone Angel, CMS Dona Coffman, CMS
PHS UPDATE
9:45	340B Program Regulations, Calculations, Processes, and Enforcement Answers from PHS Moderator: Benjamin Martin, Epstein Becker and Green • Panelists: Brand Lang, OPA • Lawrence Momodu Christopher A. Hatwig, Apexus/340B Prime Vendor Program • Lisa Scholz, PSSc
10:15	30-Minute Morning networking Break
10:45	Operational and Financial Strategies for Medicare Part D Rebates for the Coverage Gap Marla Rothouse, CMS, Bob Inserra, JNJHS
11:30	What Does it All Mean? Operational and Legal Risks and Changes to MDRP 340B and Pharmaceutical Industry Fee Alice Valder Curran, Hogan Lovells US llP
12:15 -1:30	Networking Luncheon

	TRACK A Medicaid Rebate Operations for Manufacturers	TRACK B Changes to PHS 340B Regulations	TRACK C State Contracts and Reporting Requirements	TRACK D Compliance and Analytics excellence
1:30	Chairperson's Remarks William Baxter, Ret.JNJ	Chairperson's Remarks Jimmy Mitchell, Former OPA Director	Chairperson's Remarks John Bliss, Graceway Pharmaceuticals	Chairperson's Remarks Heather Dixson, Lilly USA
1:35	Clarify Medicaid Rebate Methodology Changes to Ensure Compliant Processes Miree Lee, M. Lee Consulting Annamarie Lee, Upsher-Smith Laboratories	Operational and System Tools for Complying with 340B Program Updates Brad Lang, OPA Lawrence Momodu, OPA	Stay Compliant with New State Price Reporting Requirements Danielle Drissel, Hogan Lovells US LLP	Improve Bottom Line through Contracting Practices Analytics Ranjit , Model N
2:15	Strategies to Handle Medicare Part D Discounts for "Donut Hole" Mark Wiseman, IMS Health	Troubleshooting Manufacturer's Price Reporting Processes for 340B Program Kathleen Peterson, EBG	State Supplemental Rebate Contracts and State Pharmaceutical Assistance Programs Contract Review Ramie Zomisky, PPS	Interpreting CMS Regulations, AMP-Related Provisions and Best Practices in Government Reporting Without Clear Guidance Chris Cobourn, CIS Michael Hepburn, Jansen
3:00	30-minute Afternoon networking Break
3:30	PANEL DISCUSSION Best Practices for Auditing and Monitoring Procedures Before an OIG Audit Meghan M. Davis, JNJ Lisa Kiniklis, Biogen Idec Clarissa Crain, CIS	Implementation of Quarterly AMP and BP "True Up" Process for 340B Covered Entities Christopher Hatwig, 340B PVPr/Apexus	PANEL DISCUSSION Learn how Unfunded Mandates, Waivers and Matching lists are Affecting Medicaid Reimbursements • Sharon H. Greeson, HP NC • Tom Simonson, OK • Jeff Naber, LL	New Contract Management Strategies and Practices Following Healthcare Reform Jennifer Norton, IMANY
4:15	Industry Survey Results Revealed! Improve Processes while Complying with Changing Government Programs Environment Marijo Bustos, APP • Scott Medberry, Model N • Michael Hepburn, Jansen	340B Panel Discussion Todd LaMastres, Ernst and Young	Rebates for Medicaid Managed Care Organization (MCO) Utilization Anne Dessertine, Vertex Jennifer Dudeck, Unisys PA Corryn Russell, PA	PANEL DISCUSSION Can Compliance Become Automatic Bob Steller, Vistex James Molettiere, Cephalon Lorraine Moccio, JnJ
5:00	Networking Reception and Awards ceremony

Friday, September 16, 2011
8:00	Morning Coffee
8:30	Chairperson's Recap of Day One Edward J. McAdam, Daiichi Sankyo Inc
COMPLIANCE & ENFORCEMENT
8:45	Veterans Affairs Pricing Compliance Management Improvements Mark Myers, OIG
OIG WORK PLAN ACTIVITIES
9:15	Stay Compliant with Fraud and Abuse Provisions of Healthcare Reform • Constance Wilkinson, Epstein Becker and Green •Stephanie Yeager, OIG David Tawes, HHS OIG
10:00	Current Civil and Criminal Enforcement Activities to Improve Corporate Compliance Viveca d. Parker, USDOJ • Virginia A. Gibson, Hogan Lovells US llP • F. Elizabeth Lepic, AATG Illinios
10:45	New Strategies and Opportunities in medicaid and Medicare Mary Kay Owens, Southeastern Consultants
11:00	Morning Networking Break

	Track A Medicaid Rebate Operations	TRACK B Tricare (DoD) and VA	Track C Improve Processes for States & Pharma	Track D Small Pharmal Forum
11:30	Chairperson's Remarks William Baxter, Ret. JNJ	Chairperson's Remarks Lorraine Moccio, JNJ	Chairperson's Remarks John Bliss, Graceway Pharmaceuticals	Chairperson's Remarks Heather Dixson, Lilly USA
11:35	Clarifying Average Sale Price (ASP) Methodologies Benjamin Martin, Epstein Becker and Green Sanjida Chowdhury, APP Pharmaceuticals	Tricare Retail Pharmacy Program Final Rule Operational Implementation Strategies Amy VanDeCar, CIS Clarissa Crain, CIS •	CMS and FDA NonMatched National Drug Code List Mary Kay Owens, Southeastern Consultants	PANEL DISCUSSION: Small Company Operational and System Strategies for Managing Complex Calculations Stephanie Kupski, Graceway Pharmaceuticals • Mary Jones, LEO Pharma • Lee Lind, Cangene BioPharma • Tom Evegan, Acorda Therapeutics
12:00	Medicaid Payment Process Improvement to Avoid Pitfalls and Duplicate Discounts Phil Coburn, IMS Health	Updates on the Veteran's Health Care Act (VHCA) and FSS Contracts Catrina Hirschauer, Upsher-Smith Allison Pugsley, Hogan Lovells	Dispute Resolution Strategies to Come to a Solution Quickly Kris Flynn, Wockhardt • Peggy Watson, Amgen • Tom Simonson, OK • Brad Wallner, Talecris, Vince Powell, PPS	Three Legs to the Pharma Stool Chris Cobourn, CIS Dean Eerhardt, d2 Pharma Consulting
12:45	HOT TOPICS for Manufacturers Ryan McKinney, FTI Consulting	Session continues	Session Continues	Session Continues

1:10	Main conference concludes
1:00	Luncheon for Special Session Attendees-Sign up required
1:30- 3:30	Best Practices for Generic Companies Navigating the MDRP Panelists: Paula Grist, Wockhardt • Robert LaPorte, West Ward Pharmaceuticals • Tony Chen, Alliance Life Sciences • Kenika Withrow, Amneal Pharmaceuticals
1:00	Luncheon for Special Session Attendees-Sign up required
1:30- 3:30	5-I: Operations, Systems and Financial Answers for Handling Orphan Drugs and Specialty Products Post Healthcare Reform

pop up window

Event Navigation

Event Registration

Download Brochure

Event Sponsors

Members Login

Customer Service

Recommend

Agenda at a Glance

Agenda at a Glance

Wednesday, September 14, 2011

Thursday, September 15, 2011

Friday, September 16, 2011